This Week in Psychedelics - 1.22.21

Cannabis

• France launches public consultation on legalising cannabis (France24)

• UFC ditch marijuana ban but fighters warned to ‘temper enthusiasm’ after Usada rule change (The Independent)

• Biden Taps Marijuana Legalization Supporter To Lead Democratic National Committee (Marijuana Moment)

• American Medical Association Asks Court To Overturn Medical Marijuana Vote In Mississippi (Marijuana Moment)

• Arizona: Adult Use Marijuana Sales On Track to Begin This Month (NORML)

• This Michigan marijuana dispensary is giving free weed to anyone who got the COVID-19 vaccine (Detroit Metro Times)

• Trump Grants Clemency To Marijuana Prisoners On Last Day In Office (Marijuana Moment)

• Study: Nearly Half of Medical Cannabis Users Cease Using Opioids for Pain After Twelve Months (NORML)

• Congressman Files First Federal Marijuana Reform Bill Of 2021 (Marijuana Moment)

• Could Medical Cannabis Help with the Treatment of Movement Disorders? (Canex)

• Latest Canadian cannabis recalls include melting vape pens, moldy bud (Marijuana Business Daily)

• Virginia Marijuana Legalization Bill Approved By Senate Committee, With Home Cultivation Provisions Intact (Marijuana Moment)

• “Game changer” for the sector: First cannabis company expected to list on LSE next month (Cannabis Health News)

• Police Find 1st 'Cannabis Factory' In London's Financial District, Destroy 826 Plants (NPR)

• Hash landing: New Zealand police ditch annual helicopter hunt for cannabis dens (The Guardian)

• Phytol cited as potentially dangerous cannabis vape ingredient (Marijuana Business Daily)

• Study: Cannabis Use Associated with Reduced Alcohol Intake Among Treatment-Seeking Drinkers (NORML)

• Research establishes antibiotic potential for cannabis molecule (ScienceDaily)

• Women who use cannabis may have harder time conceiving (Healio)

• How Some THC Is Legal — For Now (Rolling Stone)

Magic Mushrooms

• Florida Lawmaker Introducing Psilocybin Mushroom Legalization (Forbes)

• Unique magic mushroom microdosing study to begin in Australia (New Atlas)

• How Mixing Mushrooms and MDMA Affects Your Body and Brain (VICE)

• Patient hopes Canada will introduce regulations for treatment with 'magic mushrooms' (CTV News)

• BC Craft Supply Co Announces Letter of Intent with Psilocybin Research and Development Company Ava Pathways (Globe Newswire)

MDMA

• MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD (Psilocybin Alpha)

Ayahuasca

• Insight into Ayahuasca’s Antidepressant Effects (Psychedelic Science Review)

5-MeO-DMT

• New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate (Psychedelic Science Review)

Synthetic Cannabinoids

• NCSA: Synthetic cannabis a cause for concern (Loop Barbados)

Ketamine

• Ketamine Clinicians Publish Ethical Guidelines to Raise Treatment Standards (Lucid News)

• Colorado officials resume review of ketamine program after Elijah McClain's death (CNN)

• PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders (Psilocybin Alpha)

Miscellaneous

• Icelandic Government Proposes Drug Decriminalisation (The Reykjavik Grapevine)

• Peter Thiel-backed psychedelics start-up targets schizophrenia ahead of IPO (CNBC)

• Psychedelic Therapy Schools Are Popping Up Like Mushrooms (Bloomberg)

• The Biden Administration and Drug Policy: Expectation Versus Reality (Filter)

• North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? (Psilocybin Alpha)

• A New Supreme Court RFRA Ruling May Be a Boon to Psychedelic Religions (Chacruna)

• Senator wants to 'lock in' 2020 drug laws (Idaho Press)

• NeonMind Lists on the Frankfurt Stock Exchange (Psilocybin Alpha)

• Is Psychedelic Medicine the Antidote to Anti-Black White Racism in the US? (Chacruna)

• The Therapeutic Potential of Psychedelics and Nature Explored in New Study (Lucid News)

• Psychedelic Authoritarianism Harm Reduction: “QAnon Shaman” Edition (Psymposia)

• Here’s What’s Missing From Conversations About Psychedelic Integration (DoubleBlind)

• Attorney General Merrick Garland a Disheartening Prospect (Filter)

• Dopamine Release and Duration of Action: Rules of Thumb to Predict Addictive Potential of Phenethylamines (Spirit Pharmacist)

• Ergot in Canada: A Lost Tradition? (Chacruna)

• BetterLife Pharma Is Developing Second Generation Psychedelics: Drugs That Leave Out The Trip (Forbes)

• Former Defence Force chief Chris Barrie supports increased accessibility of psychedelic drugs (The Canberra Times)

• Could Biden Make His Country’s Global Drug War Even More Imperialist? (Filter)

• What Will The Psychedelics Space Look Like In 2021? Experts Weigh In (Yahoo! Finance)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 1.8.21

Cannabis

• What The New Democratic-Controlled Senate Means For Federal Marijuana Legalization In 2021 (Marijuana Moment)

• These States Are The Most Likely To Legalize Marijuana In 2021 (Marijuana Moment)

• Incarcerated Patients Have A Right To Use Medical Marijuana, New Mexico Judge Rules (Marijuana Moment)

• Illinois: Governor Vacates Half a Million Past Marijuana Convictions (NORML)

• Virginia Lawmaker Introduces Bill To Legalize Marijuana In 2021 (Marijuana Moment)

• New Bill On Underage Marijuana Possession Could End New Jersey Legalization Stalemate Between Governor and Lawmakers (Marijuana Moment)

• Study: Marijuana Use Not Associated with Increased Risk of Cardiovascular Disease (NORML)

• Scientists Cite Obscure Federal Marijuana Memo In Scheduling Case Against DEA (Marijuana Moment)

• Mother fears son could die as Brexit stops medical cannabis supply (The Guardian)

• Biden AG Pick Merrick Garland Wants To Defer To DEA On Marijuana Science And Classification (Marijuana Moment)

• California: No Uptick in Frequency of Marijuana Use by Young Adults Following Adult-Use Legalization (NORML)

• New York Governor Unveils Updated Marijuana Legalization Plan For 2021 (Marijuana Moment)

LSD

• Here’s What Happens When Animals Eat LSD (DoubleBlind)

Magic Mushrooms

• This Former Latter-day Saint Politician Started a Psilocybin Church—But Is it Legal? (DoubleBlind)

• The Effects of Psilocybin on Morality and Empathy (Psychedelic Science Review)

• Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations (Psilocybin Alpha)

• Will psychedelic mushroom vacations come to the US? (The Washington Post)

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Announces New Leadership and Its Early 2021 Program Calendar (PR Newswire)

• NeonMind Goes Public, Plans To Study Functional Mushrooms And Psilocybin As Treatments (Benzinga)

MDMA

• Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders (Psilocybin Alpha)

DMT

• New Clinical Trial Explores Safety of DMT for Substance Use Disorders (Technology Networks)

5-MeO-DMT

• Hamilton Morris Synthesizes 5-MeO-DMT in “Pharmacopeia” (Psychedelic Science Review)

• A Look at: 5MEO: Are Some Doors Better Left Unopened? (Reality Sandwich)

Ketamine

• Repeated Ketamine Infusions Reduce Symptom Severity in Individuals With Chronic Post-Traumatic Stress Disorder (Newswise)

• Ethical Concerns About Marketing Ketamine as a Safe and Effective Antidepressant (Medium)

Miscellaneous

• Jake Angeli: The Psychedelic Guru Who Stormed The Capitol (Psymposia)

• Big pharma is about to tune in to the potential of psychedelics (WIRED)

• Clandestine chemistry and psychoactive drugs in film: Hamilton Morris talks about his career (Chemical and Engineering News)

• Best Music Playlists For Psychedelic Therapy Are Explored In New Johns Hopkins Study (Marijuana Moment)

• Mount Sinai Health System Launches Center for Psychedelic Research (Psilocybin Alpha)

• Tooth tartar could uncover the drug habits of ancient people (Science)

• Are the Subjective Effects of Psychedelics Necessary for Their Therapeutic Benefits? (Psychedelic Science Review)

• Oakland’s Next Step in Psychedelic Decriminalization Approved Unanimously by City Council (Lucid News)

• Neuroscientists believe deep neural networks could help illustrate how psychedelics alter consciousness (PsyPost)

• What Is Raphael Warnock’s Record on Drug Policy and Harm Reduction? (Filter)

• What do Alien Abduction and Psychedelic Experiences have in Common? Let Dr. John E. Mack’s Work Explain (Psychedelics Today)

• Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia (Psilocybin Alpha)

• God's Factory Reset (Reset.me)

• NeonMind Appoints Trevor Millar as Chief Psychedelic Officer (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.